Jonathan Noble

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Rheumatoid Arthritis

Disease Activity

Replacement Therapy

Top Venues

The European respiratory journal

This page only lists publications with an associated author ORCID identifier.

Publications

Richard Beasley, Jonathan Noble, Mark Weatherall
The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthma. The European respiratory journal 63 (6) (2024)
Richard Beasley, Jonathan Noble, Mark Weatherall
The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthma. The European respiratory journal 63 (6) (2024)
Richard Beasley, Jonathan Noble, Mark Weatherall
Clinical remission with biologic therapies in severe asthma: a matter of definition. The European respiratory journal 62 (6) (2023)
Richard Beasley, Jonathan Noble, Mark Weatherall
Clinical remission with biologic therapies in severe asthma: a matter of definition. The European respiratory journal 62 (6) (2023)
Richard Beasley, Jonathan Noble, Mark Weatherall
Clinical remission with biologic therapies in severe asthma: a matter of definition. The European respiratory journal 62 (6) (2023)
Richard Beasley, Jonathan Noble, Mark Weatherall
Clinical remission with biologic therapies in severe asthma: a matter of definition. The European respiratory journal 62 (6) (2023)
Richard Beasley, Jonathan Noble, Mark Weatherall
Clinical remission with biologic therapies in severe asthma: a matter of definition. The European respiratory journal 62 (6) (2023)